As of Feb 17
| +2.90 / +7.76%|
The 6 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 88.50, with a high estimate of 107.00 and a low estimate of 57.00. The median estimate represents a +119.88% increase from the last price of 40.25.
The current consensus among 7 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.